“There is a surprising lack of data comparing buprenorphine—the most common treatment for opioid use disorder—with no treatment. We found that the benefits of treatment were profound, substantially reducing risk of preterm birth and severe maternal morbidity.” - @stephenwpatrick.bsky.social

At least 50% of pregnant women with opioid use disorder nationwide do not receive treatment Our study in JAMA Health Forum found that buprenorphine treatment was associated with significant improvements in outcomes for mothers and infants Full paper: ja.ma/3EyF00J www.healio.com/news/pediatr...

From JAMA Health Forum: Buprenorphine treatment during pregnancy for opioid use disorder was associated with significantly improved maternal and infant outcomes compared to no treatment. #PAS2025 https://ja.ma/3EyF00J

Pregnant women with opioid use disorder face huge barriers to treatment. Our new study: Buprenorphine = fewer preterm births, fewer severe maternal complications. Treatment saves lives & we found ~5 percentage point reduction in preterm birth. Study ➔ sph.emory.edu/news/news-re...

Piece in @thenewrepublic.bsky.social cites our team's research, led by graduating Vanderbilt medical student Sunaya Krishnapura. Striking beginning to this article ... newrepublic.com/article/1935...